The TGF-β/Smad and the PI3K/AKT signaling pathways are important regulators of proliferation and apoptosis, and their alterations lead to cancer development. TGF-β acts as a tumor suppressor in premalignant cells, but it is a tumor promoter for cancerous cells. Such dichotomous actions are dictated by different cellular contexts. Here, we have unveiled a PTEN-Smad3 regulatory loop that provides a new insight in the complex cross talk between TGF-β/Smad and PI3K/AKT signaling pathways. We demonstrate that TGF-β triggers apoptosis of wild-type polarized endometrial epithelial cells by a Smad3-dependent activation of PTEN transcription, which results in the inhibition of PI3K/AKT signaling pathway. We show that specific Smad3 knockdown or knockout reduces basal and TGF-β-induced PTEN expression in endometrial cells, resulting in a blockade of TGF-β-induced apoptosis and an enhancement of cell proliferation. Likewise Smad3 deletion, PTEN knockout prevents TGF-β-induced apoptosis and increases cell proliferation by increasing PI3K/AKT/mTOR signaling. In summary, our results demonstrate that Smad3-PTEN signaling axis determine cellular responses to TGF-β.
TGF-β is a multifunctional cytokine involved in the regulation of a wide range of biological processes.
1 TGF-β signaling is initiated by ligand binding to the constitutively active dualspecificity kinase TGF-β type II receptor (TβRII). Engaged TβRII interacts with the TGF-β type I receptor (TβRI) to form tetrameric complexes. Then, TβRII transphosphorylates TβRI at the glycine-serine-rich domain. The canonical TβRs signaling is conducted by the Smad family of transcription factors. [2] [3] [4] Activation of TβR complex results in the phosphorylation of the receptor-associated Smads (R-Smads), Smad2 and Smad3, which interact with the common Smad (Co-Smad) Smad4. Smad4-R-Smad complexes can bind other DNAbinding transcription factors to modulate target gene promoter recognition and transcriptional regulation. 5 TGF-β can also trigger other signaling pathways referred as 'non-Smad' branch of TGF-β signaling 6, 7 such as the MAP kinase signaling pathway, the Rho-like GTPase signaling pathway or the phosphatidylinositol-3 kinase/AKT (PI3K/AKT) signaling pathway.
During carcinogenesis, TGF-β is a double-edge sword: it acts as a potent tumor suppressor on normal or premalignant cells, but it has a tumor promoter activity on malignant stages. [8] [9] [10] Tumor suppressive functions of TGF-β depend on its ability to induce cytostasis, apoptosis and differentiation and, loss of such responses plays a pivotal role in cancer progression. 9, 11 Emerging data demonstrate that tumor suppressive signaling induced by TGF-β is halted by oncogenic mutations. Among such alterations, those that activate the PI3K/AKT signaling pathway, antagonize cytostatic or pro-apoptotic effects of TGF-β. 12 The PI3K/AKT pathway plays a pivotal role in the regulation of cell survival and proliferation. PI3K/AKT signaling is negatively regulated by PTEN (phosphatase and tensin homolog deleted on chromosome 10), which encodes a dual lipid and protein phosphatase that antagonizes PI3K function by catalyzing the dephosphorylation of phosphatidylinositol-3,4,5-trisphosphate (PIP3) to phosphatidylinositol-4,5-trisphosphate (PIP2). 13 Alterations of PTEN increase PI3K/AKT signaling, which stimulates cell proliferation and survival.
Because both the TGF-β/Smad and the PI3K/AKT signaling pathways participate in the control of similar cellular processes, a complex interplay between these two pathways is required to coordinate cellular outcomes. 12 However, the mechanisms of cross talk between these two pathways are not completely elucidated and several models have been proposed. 12 The first one demonstrates that AKT can directly interact and retain Smad3 in the cytoplasm and the transcription of target genes that drive apoptosis triggered by TGF-β. 14, 15 A second model demonstrates that AKT phosphorylates the forkhead transcription factor (FOXO) resulting on its nuclear export, thereby interfering the formation of a FOXO/Smad transcriptional complex, which is required for cytostatic responses to TGF-β. 16 A third line of evidence demonstrates that combination of PTEN loss and Smad4 inactivation leads to tumor progression in a mouse model of prostatic cancer. 17, 18 Recently, another study demonstrated that specific genetic deletion of TβRII and PTEN ls increases intestinal tumorigenesis in mice. 19 
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Endometrial carcinoma is the most common tumor of the female genital tract. Both PI3K/AKT and TGF-β/Smad signaling pathways play a pivotal role in uterine function and physiology. 20 Female mice lacking TβRI in the reproductive tract exhibit profound defects in myometrium structure and function. 21 Moreover, ablation of TβRI in the uterus increases endometrial cell proliferation causing endometrial hyperplasia, which often precedes endometrial carcinogenesis. 22 Moreover, mutations in the PI3K/AKT signaling pathway are common in endometrial carcinogenesis. Among them, PTEN is the most frequently mutated tumor suppressor gene in endometrial carcinomas 23 and genetic ablation of PTEN in mice results in a high incidence of endometrial carcinogenesis. 24 Here, we describe a novel mechanism of interplay between PI3K/AKT and TGF-β/Smad signaling pathways that plays a pivotal role in the regulation of cell proliferation and apoptosis of endometrial epithelial cells.
Results
TGF-β triggers apoptosis of polarized endometrial epithelial cells. The effects of TGF-β on uterine endometrial epithelial cells under physiological and pathological conditions are poorly defined. To demonstrate a putative function of TGF-β1 in the regulation of endometrial physiology, we performed an immunohistochemistry analysis of TGF-β1 and its receptors TβRI and TβRII on tissue sections of normal endometrium. Immunostaining of TβRI and TβRII demonstrated that TGF-β receptors were expressed in both endometrial epithelial and stromal cells. In contrast, TGF-β1 expression was detected only in the stromal compartment (Supplementary Figure 1A) . Next, we analyzed the response of normal endometrial cells to TGF-β treatment. For this purpose, we established three-dimensional (3D) cultures of wild-type mouse endometrial epithelial cells. Under 3D culture conditions, endometrial epithelial cells develop polarized glandular structures that resemble in vivo uterine endometrial glands (Supplementary Figure 1B) . These cultures provide a good scenario to study cell autonomous responses to TGF-β. 25 We confirmed that TβRI and TβRII expression was retained in 3D cultures of endometrial epithelial cells (Supplementary Figure 1C) . Next, 3D cultures were exposed to TGF-β for 12, 24 or 36 h. TGF-β treatment caused a dose-dependent increase of nuclei displaying chromatin condensation and nuclear fragmentation typical of apoptotic cell death (Figures 1a and b) . TGF-β-induced apoptosis was further analyzed by immunofluorescence analysis of cleaved caspase-3 (Figures 1a and b) and by western blot analysis of cleaved caspase-3 and -9 ( Figure 1c ). Progressive death of 3D glandular structures was also observed and monitored by time-lapse microscopy (Supplementary Movie 1, untreated gland and Supplementary Movie 2 TGF-β-treated gland). These results suggest that TGF-β binding to its receptors triggers apoptotic cell death of polarized endometrial epithelial cells. To demonstrate that apoptosis was triggered by the activation of TGF-β signaling, we treated 3D cultures with TGF-β in presence or absence of the TβRI inhibitor, SB431542. Quantification of active caspase-3 immunofluorescence and nuclei displaying apoptotic morphology demonstrated that SB431542 was able to block TGF-β-induced apoptosis (Figure 1d ). These results suggest that activation of TGF-β signaling is required to induce apoptosis of endometrial epithelial cells.
To further investigate the molecular mechanism of TGF-β pro-apoptotic function in polarized endometrial cells, we performed a RT-quantitative real-time PCR (qPCR) analysis of genes involved in apoptosis regulation on 3D cultures exposed to TGF-β for 16 h. Among all the pro-apoptotic members of the Bcl-2 family genes analyzed (Supplementary Figure 2) , we found an increased expression of the proapoptotic BH3-only proteins BIM, BMF and NOXA (Figure 1e) . Addition of the BH3-only mimetic ABT-263 to the 3D cultures increased the number of apoptotic cells to the same extent as TGF-β treatment, suggesting that BH3-only BIM, BMF or NOXA upregulation participates in TGF-β-induced apoptosis (Figure 1f ).
Specific Smad3 deficiency hampers TGF-β-induced apoptosis. The role of R-Smads in pro-apoptotic signaling triggered by TGF-β is not completely known and both Smaddependent and Smad-independent mechanisms have been reported. 11, 26 For this reason, we analyzed R-Smad nuclear translocation upon TGF-β treatment. TGF-β stimulation of 3D cultures resulted in a rapid nuclear translocation of Smad2/3 ( Figure 2a) . To ascertain the role of such translocation in apoptosis triggered by TGF-β, we infected wild-type endometrial cells with lentiviruses carrying shRNAs targeting Smad2 (FSV-Smad2.1 and FSV-Smad2.2) or Smad3 (FSVSmad3.1 and FSV-Smad3.2) (Supplementary Figure 3a) . To demonstrate such hypothesis, we measured the levels of cyclin D1 mRNA expression and we performed BrdU incorporation assays. Smad3 − / − 3D cultures or cultures infected with Smad3 shRNA displayed a significant increase of cyclin D1 expression ( Figure 3c ) and the number of BrdU-incorporating cells (Figure 3d ). In contrast, Smad2 downregulation had no effects on cyclin D1 expression (Supplementary Figure 3C) , the number of BrdU-incorporating cells (Supplementary Figure 3D ) and glandular size (Supplementary Figure 3E) . Consistently, Smad2 − / − cells did not display increased glandular size (Supplementary Figure 3E) . These results strongly support the hypothesis that Smad3 deficiency enhances cell proliferation of polarized endometrial epithelial cells.
Smad3 regulates PTEN protein levels and AKT activation.
Alterations of PI3K/AKT signaling pathway are frequently found in endometrial cancer and other malignancies. Table 1 ).
Smad3 binds PTEN promoter to enhance its transcription. Next, we investigated the molecular mechanism by which Smad3 regulates PTEN protein levels. We first questioned whether regulation of PTEN protein levels could be caused by a Smad3-dependent regulation of PTEN transcription. For this purpose, we measured PTEN mRNA levels by RT-qPCR on Smad3-deficient cells. ShRNAmediated downregulation of Smad3 in 3D cultures resulted in a reduction of PTEN mRNA levels ( Figure 5a ). Analysis of four different Smad3 knockout litters showed a dramatic reduction of PTEN mRNA levels in Smad3 − / − epithelial endometrial cells compared to their wild-type littermates ( Figure 5b ). Importantly, Smad2 downregulation had no effect on PTEN expression (Supplementary Figure 5A) .
Next, we analyzed the role of Smad3 in TGF-β-induced PTEN expression. For this purpose, we measured PTEN mRNA levels in wild-type 3D cultures treated for different periods of time with TGF-β or TGF-β plus the TβRI inhibitor SB431542 . RT-qPCR analysis revealed a significant increase of PTEN mRNA in response to TGF-β, which was completely abrogated by SB431542 (Figure 5c ). Consistently, treatment of 3D cultures with SB431542 effectively blocked TGF-β-induced nuclear translocation of Smad2/3 (Supplementary Figure 5B) . Moreover, TGF-β-induced increase of PTEN mRNA was prevented by the transcription inhibitor actinomycin D, but not by the translation inhibitor cycloheximide (Supplementary Figure 5C) , further supporting that TGF-β/ Smad3-signaling regulates PTEN transcription. Finally, we measured PTEN mRNA levels in Smad3-deficient cultures treated with TGF-β for 12 h. Smad3 − / − cultures displayed an almost total inhibition of TGF-β-induced PTEN mRNA expression ( Figure 5d ). The apoptosis triggered by TGF-β in wild-type cells prevented the analysis of PTEN expression at longer time points. However, 3D cultures infected with Smad3 shRNAs or knockout from Smad3, the decrease in PTEN expression was maintained even 96 h after TGF-β treatment (Supplementary Figure 5D) .
To provide direct evidence that PTEN is a target gene of Smad3 transcriptional activity, we performed a chromatin immunoprecipitation (ChIP) analysis of PTEN promoter using Smad2-or Smad3-specific antibodies on unstimulated or TGF-β-treated 3D cultures. To identify putative Smad-binding sites on PTEN promoter, we analyzed three sequential 500 bp segments spanning from position − 1 to − 1500 of PTEN SMAD3-PTEN cross talk regulates TGF-β responses N Eritja et al promoter. TGF-β treatment caused a dramatic increase of Smad3-dependent immunoprecipitation of the three PTEN promoter segments, suggesting that TGF-β induces Smad3 binding to PTEN promoter (Figure 5e ). Noteworthy, unstimulated samples displayed a basal binding of Smad3 to PTEN promoter. Conversely, there was no increase of any of the three PTEN promoter regions when ChIP analysis was performed using Smad2-specific antibody (Figure 5e ). These results strongly suggest that Smad3, but not Smad2, binds to PTEN promoter to enhance its transcription upon TGF-β stimulation.
The in vitro and in vivo results supporting a Smad3-dependent regulation of PTEN protein levels in the endometrium encouraged us to investigate whether such mechanism could take place in other cells or tissues. For this reason, we analyzed PTEN mRNA expression in heart, spleen, thyroid and liver collected from Smad3 wild-type and knockout littermates. Interestingly, Smad3 − / − spleen and thyroid, but not heart and liver, displayed a significant reduction of PTEN expression when compared with their Smad3+/+ littermates (Supplementary Figure 5E ). To examine TGF-β-induced upregulation of PTEN in another cell system, we treated 3D cultures of human HEK-293T cells with TGF-β and we measured PTEN mRNA expression. Likewise in 3D cultures from endometrial murine cells, TGF-β treatment increased PTEN mRNA expression of HEK-293T cells Figure 5F ). All these results suggest that Smad3-induced PTEN expression may be a molecular mechanism that operates in different tissues or organs.
Smad3-dependent PTEN expression regulates cell proliferation and TGF-β-induced apoptosis by a PI3K/ AKT-dependent mechanism. The above results led us to hypothesize that PTEN upregulation could be regulating cell 
Discussion
The paradox of TGF-β actions during carcinogenesis is still poorly understood. In the present work, we have unveiled a normal polarized endometrial cells. To date, the molecular mechanisms by which TGF-β triggers apoptosis are not fully understood. 26, 27 Previous studies have shown that upregulation of BH3-only proteins is important for TGF-β-induced apoptosis. 28, 29 Among them, BIM has been reported to be essential for TGF-β apoptosis. [30] [31] [32] We have shown that TGF-β induces the expression of the BH3-only proteins BIM, NOXA and BMF in a Smad3-dependent manner. The blockade of TGF-β-induced apoptosis caused by ablation of either Smad3 or PTEN correlates with the inhibition of TGF-β-induced upregulation of BIM. These results support a role for the BH3-only proteins in the regulation of pro-apoptotic TGF-β signaling on endometrial epithelial cells.
Previous studies suggested that TGF-β may participate in endometrial cancer progression. It has been reported that TGF-β signaling is disrupted in endometrial carcinogenesis 33 and, downregulation of TGF-β signaling has been associated to poor prognosis. 34 Moreover, in early endometrial carcinogenesis, disabled TGF-β signaling has been associated with loss of growth inhibition. 35 In contrast, in endometrial cancer cell lines, TGF-β promotes EMT and increases invasiveness. 36 Mechanistically, we have demonstrated that the tumor suppressive functions of TGF-β/Smad3 signaling are mediated by the regulation of PI3K/AKT signaling pathway ( Figure 9 ). It has been reported that TGF-β can directly activate PI3K/AKT signaling to regulate Smad3 nuclear translocation. 7 Here, we have demonstrated that TGF-β induces Smad2/3 nuclear translocation, but independently of PI3K/AKT signaling. In the nucleus, Smad3, but not Smad2, binds to PTEN promoter and stimulates its transcription, which results in an inhibition of PI3K/AKT signaling. At the functional level, the inhibition of the PI3K/AKT pathway results in apoptotic cell death (Figure 9 ). The Smad3-dependent SMAD3-PTEN cross talk regulates TGF-β responses N Eritja et al regulation of PI3K/AKT pathway and its role in transducing tumor suppressive effects of TGF-β signaling is supported by the results obtained in Smad3-deficient cells. Smad3 loss reduces PTEN transcription, resulting in enhanced PI3K/AKT signaling and increased cell proliferation and resistance to apoptosis ( Figure 9 ). Hitherto, there are no existing evidences for a Smad3-dependent regulation of PTEN expression as a tumor suppressive mechanism for wild-type cells. Although different mechanisms of cross talk between PI3K/ AKT and TGF-β/Smad signaling have been reported, [14] [15] [16] our findings uncover a novel mechanistic model to explain the antagonism between these two pathways. We have shown that PTEN loss leads to the activation of PI3K/AKT signaling, which enhances cell proliferation and impairs TGF-β-induced apoptosis and, therefore, TGF-β suppressive functions. On the basis of our results, it is easy to speculate that loss of such tumor suppressive function may contribute to the development of endometrial hyperplasia and carcinoma in PTENdeficient mice.
The PI3K/AKT signaling pathway displays a high degree of complexity. PI3K can result in the activation of several downstream substrates apart from AKT. 37 Moreover, AKT phosphorylates many downstream substrates. 38 Here, we have uncovered PI3K/AKT/mTORC1 as a signaling axis responsible for enhanced proliferation and resistance to TGF-β-induced apoptosis in PTEN knockout cells. It is worth mentioning that mTORC1 inhibitors are currently used in clinic as a therapeutic agent. 39 Therefore, our findings, apart from new mechanistic insight, could have a therapeutic value.
Another issue that deserves discussion is the requirement of Smad2 or Smad4 to drive TGF-β-induced cellular responses. Most of cell responses triggered upon TGF-β stimulation require association of R-Smads (Smad2/3) with Smad4. However, increasing evidences demonstrate that Smad2 and Smad3 may have different roles in TGF-β signaling. 40 To conclude, our study provides a new mechanistic and functional insight into the interplay between TGF-β/Smad and PI3K/AKT signaling pathways to regulate important features of the tumoral phenotype such as cell proliferation and apoptosis. . 41 Mice were genotyped by earmarking and DNA was isolated from tail tissue in proteinase K lysis buffer. PCR was carried out with GoTaq Polymerase (Promega, Madison, WI, USA) using different pairs of primers for each gene. pten fl/fl forward primer 5'-CAAGCACTCTGCGAACTGAG-3' and reverse primer 5′-AAGT TTTTGAAGGCAAGATGC-3′; Cre-ER T+/ − forward primer 5′-ACGAACCTGGTCGA AATCGTGCG-3′ and reverse primer 5′-CGGTCGATGCAACGAGTGATGAG-3′; Smad3 − / − using a common forward primer 5′-CCACTTCATTGCCATATGCCCTG -3′ and the Smad3+/+ reverse primer 5′-CCCGAACAGTTGGATTCACACA-3′ or the Smad3 − / − reverse primer 5′-CCAGACTGCCTTGGGAAAAGC-3′. No statistical method was used to predetermine sample size. No samples and animals were excluded from the analysis. The investigators were not blinded to allocation during experiments or outcome assessment.
Isolation of endometrial epithelial cells. The isolation of endometrial epithelial cells was performed using a method previously described with minor modifications. 42 In brief, uterine horns were dissected from mice of 3-4 weeks old. Uteri were washed with Hank's balanced salt solution (HBSS) and digested with trypsin (Invitrogen). After trypsin digestion, epithelial sheets were squeezed out of the uterine pieces. Epithelial sheets were washed twice with phosphate-buffered saline (PBS) and resuspended in 1 ml of DMEM/F12 medium (Invitrogen) supplemented with 1 mM HEPES (Sigma-Aldrich), 1% of penicillin/streptomycin (Sigma-Aldrich) and fungizone (Invitrogen) (basal medium). Epithelial sheets were mechanically disrupted in basal medium. Cells were diluted in basal medium containing 2% dextran-coated charcoal-stripped (DCC-S) serum (Hyclone, Logan, UT, USA) and plated in culture dishes (BD Falcon, Bedford, MA, USA). Cells were cultured for 24 h in an incubator at 37°C with saturating humidity and 5% CO 2 .
Three-dimensional glandular cultures. Culture of endometrial epithelial cells in 3D cultures was performed as described previously 42 with minor modifications. Freshly isolated endometrial epithelial cells were plated in 24-or 6-well plastic culture plates (BD Biosciences). When required, PTEN deletion in endometrial cells isolated from Cre:ER+/ − ; Pten fl/fl mice was induced by the addition of 0.5 μg/ml of tamoxifen in culture medium. To generate Smad2 − / − endometrial cells isolated from Smad2 fl/fl mice, cells were infected with lentiviral plasmid encoding the Cre recombinase pHR-cmv-nls CRE.
After 24 h, wild-type or genetically modified cells were washed with HBSS and incubated with trypsin/EDTA solution (Sigma-Aldrich) for 5 min at 37°C. In all cases, 24 h after plating, medium was replaced by basal medium supplemented with 5 ng/ml EGF, 1 : 100 dilution of ITS supplement and 3% of fresh Matrigel. Medium was replaced every 2-3 days.
When 3D culture was established from genetically modified mice models, 3-10 pooled uteri were used to obtain endometrial epithelial cells. No statistical method was used to predetermine sample size. No specific methods for randomization were applied.
Viral production, infection and in vitro transfection conditions. Oligonucleotides to produce plasmid-based shRNA were cloned into the FSV vector using AgeI-BamHI restriction sites. shRNA target sequences were: non-targeting sequence (control shRNA sequence inserted in FSV plasmid and used as control throughout) 5′-CCTAAGGTTAAGTCGCCCTC-3′; Smad2.1: 5′-GGTGTTCAATCG CATACTAT-3′; Smad2.2: 5′-CGGTTAGATGAGCTTGAGAAA-3′; Smad3.1: 5′-CTG TCCAATGTCAACCGGAAT-3′; Smad3.2: 5′-CATCCGTATGAGCTTCGTCAA-3′.
Production of small hairpin RNA against Smad3 was achieved by transfecting HEK-293T packaging cells with linear PEI (40 μM) in combination with lentiviral plasmids (shRNA Smad3.1 and Smad3.2) and (psPAX2 packaging and pMD2G envelope) helper plasmids at 1:1:1 ratio, respectively. Similarly, the same conditions were used to produce FCIV-PTEN or CA-AKT carrying lentiviruses.
Four hours after transfection, packaging cells were cultured with DMEM supplemented with 10% FBS, 1 mmol/l HEPES (Sigma-Aldrich), 1 mmol/l sodium pyruvate (Sigma-Aldrich), 2 mmol/l L-glutamine (Sigma-Aldrich) and 1% of penicillin/ streptomycin (Sigma-Aldrich) for 3-4 days; afterwards the medium containing the viral particles was collected, centrifuged for 5 min at 200 × g and filtered through a 0.45 μM filter (Millipore, Temecula, CA, USA) and concentrated using Vivaspin concentrators (Sartorius Stedim Biotech GmbH, Gottingen, Germany). The concentrated medium containing lentiviral particles was added to growing primary cultures in basal medium. Cells were incubated for 24 h. After this period, the medium was replaced with fresh medium and cells were grown regularly to allow endogenous protein knockdown or protein overexpression.
Total RNA extraction, reverse transcriptase-PCR and quantitative real-time. For RT-qPCR, total RNA was extracted from the uterine endometrium or 3D cultures using the RNeasy Total RNA kit (Qiagen, Valencia, CA, USA) and cDNA was generated using the High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). The cDNA product was used as a template for subsequent PCR amplifications for apoptotic and anti-apoptotic members of the Bcl-2 family. Primers were designed to be complementary to the published mouse sequences and include as many known variants as possible. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin were used as a control For RT-qPCR using SYBR green, 5 μl of cDNA was combined with Maxima SYBR Green qPCR Master Mix (2 × ) (Thermo Scientific, Rockford, IL, USA), and 10 pmol of each primer in a final volume of 20 μl. After initial denaturation at 95°C for 15 min, the reaction mixture was subjected to 35 successive cycles of denaturation at 95°C for 15 s, annealing at (indicated temperatures) for 15 s, extension at 72°C for 30 s and reading at 81°C. Product purity was confirmed by dissociation curves, and random samples were subjected to agarose gel electrophoresis. Controls containing no template DNA were included in all assays, yielding no consistent amplification. The relative expression levels of each target were calculated based on the cycle threshold method.
For RT-qPCR assays using Taqman probes, the cDNA was amplified by heating to 95°C for 10 min, followed by 40 PCR cycles of 95°C for 15 s and 60°C for 1 min using the ABI Prism 7900 Sequence Detection System (Applied Biosystems) and Promega GoTaq qPCR Master Mix. Relative mRNA expression levels were calculated using the 2ΔΔCt method and are presented as ratios to the housekeeping gene GAPDH. Taqman technology from Applied Biosystems was used for real-time RT-qPCR analyses. Probes: GAPDH, Mm99999915_g1; PTEN, Mm00477208_m1; Smad2, Mm00487530_m1; Smad3, Mm01170760_m1; BIM, Mm00437796_m1. The number of cycles needed to reach the crossing point for each sample was used to calculate the amount of each product using the 2-CP method. Each sample pool was amplified in triplicate using GAPDH for normalization.
Chromatin immunoprecipitation. Endometrial epithelial cells in 3D culture (untreated and cells treated with TGFβ 10 ng/ml for 30 min) were crosslinked for 15 min at room temperature by adding 1/10 volumes of fresh 11% formaldehyde solution. Subsequently we quenched formaldehyde by adding glycine for 15 min. Cells were washed twice in ice-cold PBS and lysed. Lysate was divided in volume of 100 μl and sonicated. Sonication conditions were: 4 cycles of 30" sonication and 20" pause at 20% amplitude. This protocol was repeated for three consecutive times on ice. Finally the solution was pelleted and the supernatant transferred into a new collecting tube and saved at − 80 ºC. At this point we saved 10 μl as a whole-cell extract input. In parallel we conjugated the anti-Smad2/3 antibody to the beads. Anti-Smad2/3 conjugated beads were collected and washed with blocking buffer. About 100 μl of nuclear extracts were added to the bead solution and incubated overnight at 4°C on a rotator. After 12 h, beads were collected, incubated and washed with low and high salt buffer, next with LiCl wash buffer and finally with TE buffer. Beads were centrifuged and resuspended with elution buffer. The solution was incubated at 65°C in a heat block for 15 min. Afterwards, elution buffer was added to input. Input and pellet were incubated in the oven overnight at 65 ºC. Lysates were centrifuged and the supernatants transferred into new tubes. Supernatants were digested and incubated at 37°C for 2 h in TE buffer containing RNAseA and subsequently digested in proteinase K and incubated for 2 h at 55 ºC.
To proceed with DNA extraction, we added phenol/chloroform/isoamyl alcohol into a phaselock tube. Reverse crosslinked samples were transferred to the phaselock tubes, and centrifuged at top speed for 10 min at RT. Aqueous phase was transferred to a new tube and the DNA was precipitated by adding NaCl, glycogen and 100% EtOH. We incubated the samples at − 20°C for 4 h and then centrifuged the samples at top speed. The pellets were washed with 80% EtOH. Samples were spinned again and the pellet was resuspended in TE buffer and incubated at 65°C on a heating block for 15 min.
Immunoprecipitated DNA was subjected to qPCR analysis as described in the previous section. Primers used for qPCR were: PTEN PROMOTER − 1/ − 500 (5′-3′) (F TCGGAAAGCCGGAGGGGAG, R GTGTCTCCCGCGTGGGTCA); PTEN PROMOTER − 501/ − 986 (F TGACCCACGCGGGAGACAC, R GGCCTGGGAG GGCTCAAAG); PTEN PROMOTER − 987/ − 1459 (F CTTTGAGCCCTCC CAGGCC, R CAACCGTGGGAGAAGAGGC).
Western blotting. Cells were washed with cold PBS and lysed with lysis buffer (2% SDS, 125 mmol/l Tris-HCl, pH 6.8). Protein concentrations were determined by loading on a 10% acrylamide gel, transferring to polyvinylidene difluoride membranes (Millipore), and blotting with anti-tubulin antibody. Band density was determined by using Image Lab 4.0.1 software (Bio-Rad laboratories, Richmond, CA, USA). Equal amounts of proteins were subjected to SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. Nonspecific binding was blocked by incubation with TBST (20 mM Tris-HCl (pH 7.4), 150 mM NaCl and 0.1% Tween 20) plus 5% of non-fat milk. Membranes were incubated with the primary antibodies overnight at 4°C and for 1 h room temperature with secondary horseradish peroxidase (1:10 000 in TBST). Signal was detected with ECL Advance (Amersham-Pharmacia, Little Chalfont, Buskinghamshire, UK) and SuperSignal West Femto Trial Kit (Thermo Scientific).
Bromodeoxyuridine incorporation assay. For the determination of DNA and after the indicated treatments, 3D cultures were incubated with 3 ng/ml of 5-bromodeoxyuridine (BrdU, Sigma-Aldrich) during 15 h and then fixed with 4% paraformaldehyde for 20 min. DNA denaturation was performed with 2 mol/l HCl for 30 min. Afterwards, neutralization was done with 0.1 mol/l Na 2 B 4 O 7 (pH 8.5) for 2 min and after rinsed three times with PBS. Subsequently, block cells in PBS solution containing 5% horse serum, 5% FBS, 0.2% glycine and 0.1% Triton X-100 for 1 h. Next, cells were incubated in anti-BrdU primary monoclonal antibody (DAKO, Glostrup, Denmark), and fluorescein isothiocyanate-conjugated anti-mouse secondary antibody. Nuclei were counterstained with 5 mg/ml Hoechst 33258 and cells were visualized under an epifluorescence microscope (Leica Microsystems, Wetzlar, Germany). Nuclei were counterstained with 5 μg/ml Hoechst 33258. Cells were visualized under a confocal microscope. BrdU-positive nuclei were scored and divided by the total number of cells (visualized by Hoechst staining). The results are expressed as a percentage of BrdU-positive cells.
Immunohistochemical study. After killing, mice uteri were excised, flushed with PBS, fixed in 10% neutral-buffered formalin and embedded in paraffin. Sections (4-5 μm) were stained with hematoxylin and eosin for histopathology. Mice uterus and TMA blocks from human tissue samples were sectioned at a thickness of 3 μm, dried for 1 h at 65°C before pre-treatment procedure of deparaffinization, rehydration and epitope retrieval in the Pre-Treatment Module, PT-LINK (DAKO) at 95°C for 20 min in 50 × Tris/EDTA buffer, pH 9. Before staining the sections, endogenous peroxidase was blocked. The antibodies used were against 6H2.1 and p-AKT. After incubation, the reaction was visualized with the EnVisionTM FLEX Detection Kit (DAKO) for PTEN and EnVisionTM FLEX+ rabbit (LINKER) Detection Kit (DAKO) for p-AKT using diaminobenzidine chromogen as a substrate. Sections were counterstained with hematoxylin. Appropriate negative controls including no primary antibody were also tested.
Immunohistochemical results were evaluated by following uniform pre-established criteria. Immunostaining was graded semi-quantitatively by considering the percentage and intensity of the staining. A histological score was obtained from each sample and values ranged from 0 (no immunoreaction) to 300 (maximum immunoreactivity). The score was obtained by applying the following formula, Histoscore = 1 × (% light staining)+2 × (% moderate staining)+3 × (% strong staining). The histological score was also used for evaluation of cytosolic and nuclear staining intensity.
To support the scoring of immunohistochemistry an automated imaging system, the ACIS III Instrument (DAKO), was also used. An intensity score, which ranged from 60 to 255, was obtained from four different areas of each sample.
Immunofluorescence. Endometrial epithelial cells in 3D cultures were fixed with formalin for 5 min at room temperature, and washed twice with PBS. Depending on primary antibody, cells were permeabilized with 0.2% Triton (T) X-100 in PBS for 10 min or with 100% methanol (Me) for 2 min. Next, cultures were incubated overnight at 4°C with the indicated dilutions of antibodies: cleaved caspase-3 (T), α-tubulin (T), total Smad2/3 (T), TβRI (T), TβRII (T) and anti-Smad4 (Me). After 1 day, cells were washed twice with PBS and incubated with PBS containing 5 μg/ml of Hoechst 33342 and a 1:500 dilution of Alexa Fluor secondary anti-mouse or anti-rabbit antibodies for 4 h at room temperature. For double-immunofluorescence staining, cells were incubated with the second round of primary and secondary antibodies. In all doubleimmunofluorescence stains, first and second primary antibodies were from a different isotype. Immunofluorescence staining was visualized and analyzed using confocal SMAD3-PTEN cross talk regulates TGF-β responses N Eritja et al
